Identification of a new androgen receptor (AR) co‐regulator BUD31 and related peptides to suppress wild‐type and mutated AR‐mediated prostate cancer growth via peptide screening and X‐ray structure analysisCheng-Lung Hsu, Chawnshang Chang, Shauh-Der Yeh et al.|Molecular Oncology|2014Cited by 58
Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3Jong‐Wei Hsu, Yi-Fen Lee, Sayeda Yasmin‐Karim et al.|American Journal Of Pathology|2011Cited by 56
Vitamin D receptor-binding site variants affect prostate cancer progressionVictor C. Lin, Bo‐Ying Bao, Shu‐Pin Huang et al.|Oncotarget|2017Cited by 13
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screeningCheng-Lung Hsu, Wen-guey Wu, Ting-Wei Lin et al.|Oncotarget|2017Cited by 6